Detalhe da pesquisa
1.
Structural deficits in key domains of Shank2 lead to alterations in postsynaptic nanoclusters and to a neurodevelopmental disorder in humans.
Mol Psychiatry
; 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450866
2.
Missense mutations in CASK, coding for the calcium-/calmodulin-dependent serine protein kinase, interfere with neurexin binding and neurexin-induced oligomerization.
J Neurochem
; 157(4): 1331-1350, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090494
3.
The Shank/ProSAP N-Terminal (SPN) Domain of Shank3 Regulates Targeting to Postsynaptic Sites and Postsynaptic Signaling.
Mol Neurobiol
; 61(2): 693-706, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656313
4.
Regulation of Liprin-α phase separation by CASK is disrupted by a mutation in its CaM kinase domain.
Life Sci Alliance
; 5(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137748
5.
Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders.
Sci Rep
; 12(1): 902, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042901
6.
Functional analysis of CASK transcript variants expressed in human brain.
PLoS One
; 16(6): e0253223, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34133460